News & Events
iCAD & ProFound Breast Health Suite in the News
Press Releases
SABCS 2024: New Research Assesses iCAD’s Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations
Reveals Higher Prevalence of Breast Arterial Calcifications (BAC) in Breast Cancer Patients, Suggesting Potential Need for Cardiovascular Assessment Alongside Oncological Treatment NASHUA, N.H., December 11, 2024 — iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader in clinically proven AI-powered cancer detection solutions, announced today that four novel…
iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024
ProFound Health, a Virtual Care Partnership with Cascaid Health, to Democratize Access to AI-Powered Mammography for All Patients – Launching Q1 2025 NASHUA, N.H., November 26, 2024 — iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, will showcase its groundbreaking…
iCAD Reports Financial Results for Third Quarter Ended September 30, 2024
NASHUA, N.H. – November 13, 2024 – iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three and nine months…
In the Media
Exploring Artificial Intelligence (AI) in Oncology
Oncology Data Advisor – Podcast
Upcoming Tradeshows & Meetings
No Events Found
Webinars
Case Review with ProFound AI Detection Solutions, Presented by Dr. Rafaele Vautrin, Radiologist at Imapole Lyon Villeurbanne
Dr. Vautrin, a user of iCAD’s ProFound AI solution for 2D and 3D mammography for nearly two years, shares her experience through a series of clinical cases where the AI-provided insights were crucial in detecting cancer in her patients.
Symposium JFR 2024
Apport des solutions d’intelligence artificielle d’iCAD pour un meilleur dépistage du cancer du sein détection, densité et risque : revue des dernières études cliniques et revue de cas. Présenté par Pr Bruno Boyer, CIMI, Paris
Revue de cas cliniques avec les solutions ProFound AI détection, présentés par le Dr Rafaele Vautrin, Radiologue à Imapole Lyon Villeurbanne.
Utilisatrice de la solution ProFound IA d’iCAD pour les mammographies 2D et 3D depuis près de deux ans, le Dr Vautrin partage son retour d’expérience au travers d’une dizaine de cas cliniques pour lesquels les informations fournies par l’IA se sont avérées déterminantes pour détecter des cancers chez ses patientes.
Contact Us
Together, we can create a world where cancer can’t hide.
Ready to experience how ProFound can save lives?